Marco Donia

57PUBLICATIONS
168CO-AUTHORS
Tumour immunologyMolecular targetsGene and molecular therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Jun 25, 2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.

|Jun 17, 2026
Quantifying the efficacy-effectiveness gap in first line treatment of metastatic melanoma.

|May 18, 2026
Phenotypic and Functional Characteristics of CD8+ T Cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma.

|Apr 29, 2026
Real-World Outcomes of Nivolumab and Ipilimumab in Metastatic Melanoma as Third Line and Beyond.

|Apr 24, 2026
Tumor Infiltrating Lymphocyte Therapy Combined With PD-1/LAG-3 Inhibition in Patients With Recurrent Platinum-Resistant Ovarian Cancer.

|Feb 12, 2026
Immune Cell Modulation of Patient-Matched Organoid Drug Response in Precision Cancer Medicine Platform.

Silje Kjølle, Mario Presti, Jéssica de Pina Roque

Pageof 10

Frequent Collaborators

25 joint publications

Inge Marie Svane

11 joint publications

Eva Ellebaek

9 joint publications

Troels Holz Borch

8 joint publications

Arianna Draghi